In the last trading session, 1.07 million shares of the Wave Life Sciences Ltd (NASDAQ:WVE) were traded, and its beta was -0.77. Most recently the company’s share price was $6.00, and it changed around $0.35 or 6.19% from the last close, which brings the market valuation of the company to $920.94M. WVE currently trades at a discount to its 52-week high of $16.74, offering almost -179.0% off that amount. The share price’s 52-week low was $4.25, which indicates that the current value has risen by an impressive 29.17% since then. We note from Wave Life Sciences Ltd’s average daily trading volume that its 10-day average is 1.86 million shares, with the 3-month average coming to 1.17 million.
Wave Life Sciences Ltd stock received a consensus recommendation rating of Buy, based on a mean score of 1.17. If we narrow it down even further, the data shows that 0 out of 12 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 1 recommended WVE as a Hold, whereas 9 deemed it a Buy, and 0 rated it as Underweight.
Wave Life Sciences Ltd (NASDAQ:WVE) trade information
Instantly WVE has showed a green trend with a performance of 6.19% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 6.26 on recent trading dayincreased the stock’s daily price by 4.15%. The company’s shares are currently down -51.50% year-to-date, but still up 3.45% over the last five days. On the other hand, Wave Life Sciences Ltd (NASDAQ:WVE) is -41.29% down in the 30-day period. We can see from the shorts that 9.94 million shares have been sold at a short interest cover period of 7.3 day(s).
The consensus price target as assigned by Wall Street analysts is $22, which translates to bulls needing to increase their stock price by 72.73% from its current value. Analyst projections state that WVE is forecast to be at a low of $15 and a high of $36.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 34.27%. Wave Life Sciences Ltd earnings are expected to increase by -37.40% in 2025, but the outlook is positive 0.13% per year for the next five years.
WVE Dividends
Wave Life Sciences Ltd’s next quarterly earnings report is expected to be released on 2025-Mar-03.
Wave Life Sciences Ltd (NASDAQ:WVE)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 16.53% of Wave Life Sciences Ltd shares, and 83.47% of them are in the hands of institutional investors. The stock currently has a share float of 100.00%. Wave Life Sciences Ltd stock is held by 245.0 institutions, with RA CAPITAL MANAGEMENT, L.P. being the largest institutional investor. By 2024-06-30, it held 14.0527% of the shares, which is about 18.2 million shares worth $90.83 million.
MAVERICK CAPITAL LTD, with 5.9211% or 7.67 million shares worth $38.27 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund and iShares Trust-iShares Russell 2000 ETF were the top two Mutual Funds as of Jan 31, 2025 . The former held 2.44 shares worth $14.65 million, making up 1.59% of all outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held roughly 2.38 shares worth around $14.26 million, which represents about 1.55% of the total shares outstanding.
